SipNose is based on a professional and experienced team that combines expertise in technology, engineering, medical applications and science together with managing and product development proficiency.
Dr. Shichor brings to SipNose her extensive experience in leading research and development programs and managing product development projects from concept to product. Dr. Shichor holds a Ph.D. from the Hebrew University of Jerusalem with strong expertise in biochemistry and physiology, neuroscience and drug delivery systems. Before co-founding SipNose, Dr. Shichor was VP R&D at ClearFarma. Her previous experience includes a post-doctoral fellowship in the laboratory of Prof. Robert Langer (Harvard-MIT Division of Health Sciences and Technology (HST) where she focused on controlled release local anesthetic formulations, and a position as a senior scientist and project leader at NanoCyte Ltd. where she developed an innovative platform technology for transdermal delivery.
Chief Executive Officer
Chief Technology Officer
Mr. Daniel Shahaf brings to SipNose years of extensive experience as a successful inventor, developer and entrepreneur in the field of medical platforms for the human respiratory system. Mr. Shahaf brings a vast understanding of stress elimination significance in respiratory drug applications. Prior to co-founding SipNose, Mr. Shahaf lead the development and engineering of several projects in the field of nanotechnology based diagnostics at the Alfred Man institute at the Technion institute of technology, Israel. Mr. Shahaf brings a vast experience in managing product development projects and consulting in a broad range of industrial projects around the world. Education: Animal physiology- the faculty of agriculture, Hebrew University of Jerusalem.
Chief Business Officer
Mr. Eric Keller has more than 25 years experience representing and leading technology based companies is the areas of biotech, material science, software and media, and brings extensive experience in business development, strategic alliances, joint ventures and intellectual property. He is the Executive Chairman at C2Sense, a developer of sensors for the food and agriculture and industrial safety industries, and Founder and CEO of nPute, a mobile application development company. Previously, he was a co-Founder and CEO at Nano Terra, a Boston-based nanotechnology company with life science and non-life science divisions. He has also held senior roles at MediaTek/DMCC, T-Ink, and Lincoln Holdings/Washington Capitols, and was one of the chief deal architects at America Online. Mr. Keller holds an A.B. from Harvard College and a J.D. from Boston College, and practiced securities, venture capital, and technology company law in Boston and Washington, DC.
At SipNose we collaborate with first in line academia and industry professionals to design and develop the next generation nasal delivery device and products.
Board of Directors:
Moshe Mizrahy - co-founder and CEO of Home Skinovations and Invasix
Iftah Poran - Founder Studio PoranAran, Industrial Design & Product Development
Ariel Meyuhas - Founder and COO The MAX Group
Hadar Ron, PhD - Managing Partner, Israel HealthCare Ventures
Scientific and Business Advisory Board:
Professor Tamir Ben-Hur, MD. PhD. - Head of Department of Neurology, Hadassah Medical Center, Jerusalem.
Professor Natan Bornstein, MD. - Head of Stroke Unit, Neurology Department, Tel Aviv Sourasky Medical Center and professor of Neurology at the Tel Aviv University, Sackler Faculty of Medicine.
Dr. Moshe Bocher, MD. - Department of Medical Biophysics and Nuclear Medicine, Hebrew University, Hadassah Medical School, Jerusalem, Israel.
Michal Preminger, PhD., MBA - Executive Director, Office of Technology Development, Harvard Medical School.
Mally Arad, MBA - President, Global Project Partners LLC.
Carol Nast, MBA - President, Enterprise Catalyst Group, Inc